基础医学与临床 ›› 2025, Vol. 45 ›› Issue (9): 1151-1157.doi: 10.16352/j.issn.1001-6325.2025.09.1151

• 研究论文 • 上一篇    下一篇

ACE2蛋白Cys141、Cys344和Cys498位点的棕榈酰化修饰促进其在细胞外囊泡的定位

阳晶晶1, 马艳1, 王悦1, 孙阳2, 李盼2*, 郭峰1*   

  1. 1.徐州医科大学 基础医学院 江苏省免疫与代谢重点实验室 病原生物学与免疫学教研室,江苏 徐州 221004;
    2.徐州医科大学 细胞治疗产业学院 江苏省肿瘤生物治疗研究所,江苏 徐州 221121
  • 收稿日期:2025-06-03 修回日期:2025-07-09 出版日期:2025-09-05 发布日期:2025-08-27
  • 通讯作者: *PanLi@xzhmu.edu.cn; Feng.Guo@xzhmu.edu.cn
  • 基金资助:
    国家自然科学基金(82370051,82373905);江苏省研究生科研与实践创新计划项目(KYCX23_2944);基础医学国家级实验教学示范中心学生科创项目(2024BMS29)

Palmitoylation of ACE2 at Cys141, Cys344, and Cys498 facilitates its extracellular vesicles localization

YANG Jingjing1, MA Yan1, WANG Yue1, SUN Yang2, LI Pan2*, GUO Feng1*   

  1. 1. Jiangsu Province Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Basic Medical School, Xuzhou Medical University, Xuzhou 221004;
    2. State Key Laboratory Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou 221121, China
  • Received:2025-06-03 Revised:2025-07-09 Online:2025-09-05 Published:2025-08-27
  • Contact: *PanLi@xzhmu.edu.cn; Feng.Guo@xzhmu.edu.cn

摘要: 目的 鉴定严重急性呼吸系统综合征冠状病毒(SARS-CoV)和SARS-CoV-2细胞受体——血管紧张素转化酶2(ACE2)的关键S-棕榈酰化修饰位点,并探讨该修饰对ACE2定位和功能的影响。方法 通过多位点突变策略,将ACE2蛋白的8个半胱氨酸(Cys)残基全部突变为丝氨酸,获得无棕榈酰化能力的突变体(8CS)。随后在该背景下逐一回突单个半胱氨酸残基,通过点击化学结合生物正交标记方法,检测各突变体的棕榈酰化修饰水平,筛选可能发生棕榈酰化的关键位点。进一步结合免疫荧光染色及细胞外囊泡提取实验,评估各修饰位点对ACE2定位的影响。结果 优化了基于点突变技术的多位点棕榈酰化筛选体系,鉴定出ACE2蛋白的3个关键棕榈酰化位点:Cys141、Cys344 和 Cys498。功能研究表明,这些位点的棕榈酰化修饰显著促进ACE2向细胞外囊泡的富集。结论 ACE2蛋白Cys141、Cys344 和 Cys498位点发生的S-棕榈酰化修饰是其靶向细胞外囊泡定位的重要因素,提示其可能在病毒受体呈递和ACE2相关信号通路中发挥重要作用。

关键词: S-棕榈酰化, 多点突变, 翻译后修饰, 细胞外囊泡, 血管紧张素转化酶2(ACE2)

Abstract: Objective To identify S-palmitoylation sites on angiotensin-converting enzyme 2(ACE2), the cellular receptor for severe acute respiratory syndrome corona virus(SARS-CoV) and SARS-CoV-2, and to investigate the functional relevance of these modifications in regulating ACE2 localization and activity. Methods An optimized multi-site mutagenesis strategy was performed by simultaneously substitution of all eight cysteine (Cys) residuesin ACE2 by serine to create a non-palmitoylatable mutant (8CS). Then individual cysteine residues were re-introduced one by one. Palmitoylation level of mutants was evaluated using a bioorthogonal click chemistry method to identify palmitoylation-competent residues. Immune-fluorescence staining and extra-cellular vesicle isolation assays were then used to evaluate the impact of specific palmitoylation sites on ACE2 sub-cellular localization. Results An efficient strategy for multi-site palmitoylation site mapping was optimized and successfully identified three critical palmitoylation sites on ACE2: Cys141, Cys344 and Cys498. Functional analyses showed that palmitoylation of these sites significantly promotes the enrichment of ACE2 in extra-cellular vesicles. Conclusions S-palmitoylation at Cys141, Cys344 and Cys498 is essential for the trafficking of ACE2 to extra-cellular vesicles, which suggests a potential regulatory mechanism of its impact on viral receptor presentation and ACE2-associated signaling pathways.

Key words: S-palmitoylation, multi-site mutagenesis, post-translational modification, extra cellular vesicle, angiotensin-converting enzyme 2(ACE2)

中图分类号: